TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Organon & Co (OGN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 07/31/2026
Earnings surprise by quarter (%)
Q3 23 · -17.9 % 23 Q4 23 · 6.0 % 23 Q1 24 · 31.2 % 24 Q2 24 · 3.7 % 24 Q3 24 · -3.3 % 24 Q4 24 · 3.5 % 24 Q1 25 · 14.6 % 25 Q2 25 · 6.4 % 25 Q3 25 · 8.6 % 25 Q4 25 · -13.7 % 25 Q1 26 · -16.5 % 26 Q2 26 · -5.9 % 26

EPS estimate beaten

Full history 15 of 22 quarters (68%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 07/31/2026 Organon & Co. (OGN): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/23/2026 Organon & Co. (OGN): Submission of Matters to a Vote of Security Holders · sec.gov Open ↗
  • 07/17/2026 Organon & Co. (OGN): Other Events · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?